Dunelm, AstraZeneca and Persimmon cut

July 04, 2023 at 04:28 am EDT

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

----------

FTSE 100

----------

JPMorgan raises Centrica price target to 150 (140) pence - 'overweight'

----------

UBS cuts Vodafone price target to 100 (105) pence - 'buy'

----------

Barclays cuts Airtel Africa price target to 175 (195) pence - 'overweight'

----------

Berenberg cuts AstraZeneca price target to 13,300 (13,500) pence - 'buy'

----------

Deutsche Bank cuts AstraZeneca to 'hold' - price target 11,000 pence

----------

Barclays cuts Haleon price target to 378 (400) pence - 'overweight'

----------

Deutsche Bank cuts Haleon price target to 340 (350) pence - 'hold'

----------

Bernstein cuts Reckitt price target to 6,700 (7,000) pence - 'market-perform'

----------

JPMorgan cuts Persimmon to 'neutral' (overweight) - price target 1,090 (1,600) pence

----------

JPMorgan cuts Taylor Wimpey price target to 94 (130) pence - 'neutral'

----------

JPMorgan cuts Barratt Developments price target to 390 (430) pence - 'neutral'

----------

JPMorgan cuts Berkeley Group price target to 4,400 (4,800) pence - 'overweight'

----------

Goldman Sachs raises St James's Place price target to 1,340 (1,335) pence - 'buy'

----------

JPMorgan cuts JD Sports Fashion price target to 210 (215) pence - 'overweight'

----------

FTSE 250

----------

Barclays cuts Liontrust Asset Management target to 1,000 (1,040) pence - 'overweight'

----------

RBC cuts Dunelm to 'underperform' (sector perform) - price target 1,000 (1,300) pence

----------

JPMorgan cuts Redrow price target to 370 (440) pence - 'underweight'

----------

JPMorgan cuts Crest Nicholson price target to 150 (200) pence - 'underweight'

----------

JPMorgan cuts Bellway price target to 2,200 (2,780) pence - 'overweight'

----------

JPMorgan cuts Vistry price target to 580 (740) pence - 'underweight'

----------

SMALL CAP

----------

Jefferies raises Foresight Group price target to 560 (540) pence - 'buy'

----------

Barclays cuts Petrofac price target to 90 (200) pence - 'equal weight'

----------

Market Closed - London S.E. Other stock markets 11:35:09 2024-04-26 am EDT			5-day change	1st Jan Change
11,988 ^GBX	-0.32%		+9.52%	+13.09%

Apr. 26	ASTRAZENECA : DZ Bank sticks Neutral	ZD
Apr. 26	ASTRAZENECA : UBS keeps a Sell rating	ZD

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
FTSE MID 250 INDEX	19,824 PTS	+1.13%	+1.92%	-
ASTRAZENECA PLC	11,988 GBX	-0.32%	+9.52%	231B
BIST 100	9,916 PTS	+2.05%	+4.11%	-
FTSE 100	8,140 PTS	+0.75%	+3.09%	-
THE BERKELEY GROUP HOLDINGS PLC	4,702 GBX	+1.07%	+3.52%	6.2B
RECKITT BENCKISER GROUP PLC	4,423 GBX	+1.54%	+6.14%	38.86B
BELLWAY P.L.C.	2,546 GBX	+2.00%	+4.34%	3.76B
S&P UNITED KINGDOM (PDS)	1,650 PTS	+0.76%	+3.55%	-
PERSIMMON PLC	1,318 GBX	+2.77%	+2.49%	5.25B
MSCI UNITED KINGDOM (STRD)	1,213 USD	+0.54%	+3.65%	-
VISTRY GROUP PLC	1,174 GBX	+3.07%	+5.39%	4.98B
DUNELM GROUP PLC	994 GBX	+1.12%	+2.05%	2.5B
LIONTRUST ASSET MANAGEMENT PLC	669 GBX	+2.29%	-2.62%	532M
REDROW PLC	644.5 GBX	+1.42%	+2.63%	2.58B
DOW JONES AFRICA TITANS 50 INDEX	462 PTS	+1.81%	+1.69%	-
BARRATT DEVELOPMENTS PLC	454.9 GBX	+1.36%	+3.04%	5.49B
FORESIGHT GROUP HOLDINGS LIMITED	440 GBX	-0.90%	0.00%	635M
ST. JAMES'S PLACE PLC	435.4 GBX	+3.42%	+2.93%	2.96B
HALEON PLC	334.4 GBX	+0.87%	+2.64%	38.04B
BARCLAYS PLC	204.4 GBX	+0.17%	+9.96%	38.15B
CREST NICHOLSON HOLDINGS PLC	185.9 GBX	+0.49%	-0.32%	594M
S&P AFRICA 40 INDEX	157.6 PTS	+3.21%	+3.26%	-
TAYLOR WIMPEY PLC	134.3 GBX	+2.17%	+2.72%	5.92B
CENTRICA PLC	133.7 GBX	+1.75%	+1.52%	8.8B
JD SPORTS FASHION PLC	120.2 GBX	+3.31%	+2.74%	7.76B
AIRTEL AFRICA PLC	109.8 GBX	+1.20%	+1.86%	5.12B
VODAFONE GROUP PLC	69.08 GBX	+0.12%	+3.10%	23.3B
PETROFAC LIMITED	22.3 GBX	-5.27%	-3.96%	145M
DEUTSCHE BANK AG	16.53 EUR	-0.77%	+10.55%	34.79B

ASTRAZENECA : DZ Bank sticks Neutral	Apr. 26	ZD
ASTRAZENECA : UBS keeps a Sell rating	Apr. 26	ZD
ASTRAZENECA : Deutsche Bank remains Neutral	Apr. 26	ZD
ASTRAZENECA : Gets a Buy rating from Barclays	Apr. 26	ZD
Barclays Raises AstraZeneca PT, Affirms at Overweight	Apr. 26	MT
Peel Hunt cuts ConvaTec to 'reduce'	Apr. 26	AN
THE FTSE 100 is on a roll	Apr. 26
Health Care Drops Amid Mixed Earnings -- Health Care Roundup	Apr. 25	DJ
Sector Update: Health Care Stocks Decline Late Afternoon	Apr. 25	MT
Sector Update: Health Care Stocks Drop in Afternoon Trading	Apr. 25	MT
Top Midday Stories: Shares of Meta, IBM, Caterpillar, Comcast and Southwest Down Big Post-Earnings; AstraZeneca Shares See Post-Earnings Bump	Apr. 25	MT
ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade	Apr. 25
FTSE 100 shakes off red-hot US inflation gauge	Apr. 25	AN
Global markets live: Ford, Dow, American Airlines, Comcast, Apple, IBM, Cisco...	Apr. 25
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	Apr. 25	MT
ASTRAZENECA : UBS maintains a Sell rating	Apr. 25	ZD
Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday	Apr. 25	MT
The specter of stagflation rears its ugly head again	Apr. 25
Dpa-AFX Overview: COMPANIES from 25.04.2024 - 15:15	Apr. 25	DP
Sector Update: Health Care	Apr. 25	MT
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Key Economic Data	Apr. 25	MT
ASTRAZENECA : Jefferies sticks Neutral	Apr. 25	ZD
ASTRAZENECA : JP Morgan remains its Buy rating	Apr. 25	ZD
FTSE 100 hits high on offer for Anglo American	Apr. 25	AN
Transcript : AstraZeneca PLC, Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25

	1st Jan change	Capi.
ASTRAZENECA PLC	+13.09%	231B
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B
PFIZER, INC.	-11.77%	144B

AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Dunelm, AstraZeneca and Persimmon cut

Stocks mentioned in the article

Latest news about AstraZeneca PLC

Chart AstraZeneca PLC

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for AstraZeneca PLC

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals